Cutaneous manifestations secondary to panitumumab therapy. Lavery MJ, Forsyth L, Hindle E. Clin Dermatol 2021;39:887-889.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lavery MJ, Forsyth L, Hindle E. Cutaneous manifestations secondary to panitumumab therapy. Clin Dermatol 2021;39:887-889.
PMID: 34785017